The impact of cisplat based chemotherapy on advanced ovarian cancer

Autor:	Prasad G, Dalal A, Tongaonkar H, Chatterjee S, Kamat M
Jazyk:	angličtina
Rok vydání:	1995
Předmět:	Ovarian Neoplasms administration & dosage lcsh:R lcsh:Medicine drug therapy surgery Survival Rate Methotrexate Treatment Outcome Doxorubicin Antineoplastic Combined Chemotherapy Protocols Comparative Study Female pathology Fluorouracil Cisplatin Cyclophosphamide Human
Zdroj:	Journal of Postgraduate Medicine, Vol 41, Iss 4, Pp 95-8 (1995)
ISSN:	0972-2823 0022-3859
Popis:	Cisplatinum based chemotherapy has become the standard treatment for ovarian cancers due to its proved superiority over non-cisplat based regimes. However, the therapeutic impact of cisplat based regimes compared to cheaper non-cisplatinum based regimes is questionable when multiple variables such as residual disease, histologic type, grade are introduced. This report is a study of 110 Stage III ovarian cancer patients from 1985-89, with cisplat (n = 69) and non cisplat (n = 41) based chemotherapy. The results of both regimes with reference to the multiple variable factors are presented. We conclude that cisplat based regimes appear to be superior to non-cisplat based regimes except probably in poorly differentiated ovarian tumors where the results were similar with either regimen.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doajarticles::8dd005b81c6adf6f11f20db57eb594c4 http://www.jpgmonline.com/article.asp?issn=0022-3859 Zobrazit plný text záznamu